These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 25249788)

  • 1. Oxidative stress-induced premature senescence in Wharton's jelly-derived mesenchymal stem cells.
    Choo KB; Tai L; Hymavathee KS; Wong CY; Nguyen PN; Huang CJ; Cheong SK; Kamarul T
    Int J Med Sci; 2014; 11(11):1201-7. PubMed ID: 25249788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Oxidative Stress Effects on Senescence Patterning of Human Adult and Perinatal Tissue-Derived Stem Cells in Short and Long-term Cultures.
    Facchin F; Bianconi E; Romano M; Impellizzeri A; Alviano F; Maioli M; Canaider S; Ventura C
    Int J Med Sci; 2018; 15(13):1486-1501. PubMed ID: 30443170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutaminase-1 inhibition alleviates senescence of Wharton's jelly-derived mesenchymal stem cells via senolysis.
    Lee EJ; Kim SJ; Jeon SY; Chung S; Park SE; Kim JS; Choi SJ; Oh SY; Ryu GH; Jeon HB; Chang JW
    Stem Cells Transl Med; 2024 Sep; 13(9):873-885. PubMed ID: 39120480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
    Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA
    Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Culturing on Wharton's jelly extract delays mesenchymal stem cell senescence through p53 and p16INK4a/pRb pathways.
    Hao H; Chen G; Liu J; Ti D; Zhao Y; Xu S; Fu X; Han W
    PLoS One; 2013; 8(3):e58314. PubMed ID: 23516461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrogen peroxide preconditioning enhances the therapeutic efficacy of Wharton's Jelly mesenchymal stem cells after myocardial infarction.
    Zhang J; Chen GH; Wang YW; Zhao J; Duan HF; Liao LM; Zhang XZ; Chen YD; Chen H
    Chin Med J (Engl); 2012 Oct; 125(19):3472-8. PubMed ID: 23044308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PARKIN overexpression in human mesenchymal stromal cells from Wharton's jelly suppresses 6-hydroxydopamine-induced apoptosis: Potential therapeutic strategy in Parkinson's disease.
    Bonilla-Porras AR; Arevalo-Arbelaez A; Alzate-Restrepo JF; Velez-Pardo C; Jimenez-Del-Rio M
    Cytotherapy; 2018 Jan; 20(1):45-61. PubMed ID: 29079356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of human mesenchymal stem cells (MSC) to dopaminergic neurons: A comparison between Wharton's Jelly and olfactory mucosa as sources of MSCs.
    Alizadeh R; Bagher Z; Kamrava SK; Falah M; Ghasemi Hamidabadi H; Eskandarian Boroujeni M; Mohammadi F; Khodaverdi S; Zare-Sadeghi A; Olya A; Komeili A
    J Chem Neuroanat; 2019 Mar; 96():126-133. PubMed ID: 30639339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and clinical applications of Wharton's jelly-derived mesenchymal stromal cells.
    Liau LL; Ruszymah BHI; Ng MH; Law JX
    Curr Res Transl Med; 2020 Jan; 68(1):5-16. PubMed ID: 31543433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving stemness and functional features of mesenchymal stem cells from Wharton's jelly of a human umbilical cord by mimicking the native, low oxygen stem cell niche.
    Obradovic H; Krstic J; Trivanovic D; Mojsilovic S; Okic I; Kukolj T; Ilic V; Jaukovic A; Terzic M; Bugarski D
    Placenta; 2019 Jul; 82():25-34. PubMed ID: 31174623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are serum-free and xeno-free culture conditions ideal for large scale clinical grade expansion of Wharton's jelly derived mesenchymal stem cells? A comparative study.
    Swamynathan P; Venugopal P; Kannan S; Thej C; Kolkundar U; Bhagwat S; Ta M; Majumdar AS; Balasubramanian S
    Stem Cell Res Ther; 2014 Jul; 5(4):88. PubMed ID: 25069491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of anti-fibrotic factors ameliorates anti-fibrotic properties of Wharton's jelly derived mesenchymal stem cells under oxidative damage.
    Nimsanor N; Phetfong J; Kitiyanant N; Kamprom W; Supokawej A
    Biosci Trends; 2019 Nov; 13(5):411-422. PubMed ID: 31656260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DMSO- and Serum-Free Cryopreservation of Wharton's Jelly Tissue Isolated From Human Umbilical Cord.
    Shivakumar SB; Bharti D; Subbarao RB; Jang SJ; Park JS; Ullah I; Park JK; Byun JH; Park BW; Rho GJ
    J Cell Biochem; 2016 Oct; 117(10):2397-412. PubMed ID: 27038129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herbal pre-conditioning induces proliferation and delays senescence in Wharton's Jelly Mesenchymal Stem Cells.
    Sanap A; Chandravanshi B; Shah T; Tillu G; Dhanushkodi A; Bhonde R; Joshi K
    Biomed Pharmacother; 2017 Sep; 93():772-778. PubMed ID: 28724259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human chorionic-plate-derived mesenchymal stem cells and Wharton's jelly-derived mesenchymal stem cells: a comparative analysis of their potential as placenta-derived stem cells.
    Kim MJ; Shin KS; Jeon JH; Lee DR; Shim SH; Kim JK; Cha DH; Yoon TK; Kim GJ
    Cell Tissue Res; 2011 Oct; 346(1):53-64. PubMed ID: 21987220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation, Expansion, and Characterization of Wharton's Jelly-Derived Mesenchymal Stromal Cell: Method to Identify Functional Passages for Experiments.
    Aung SW; Abu Kasim NH; Ramasamy TS
    Methods Mol Biol; 2019; 2045():323-335. PubMed ID: 31201682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53-NF-κB Crosstalk in Febrile Temperature-Treated Human Umbilical Cord-Derived Mesenchymal Stem Cells.
    Goyal U; Ta M
    Stem Cells Dev; 2019 Jan; 28(1):56-68. PubMed ID: 30319075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of non-muscle myosin II leads to G0/G1 arrest of Wharton's jelly-derived mesenchymal stromal cells.
    Sharma T; Kumari P; Pincha N; Mutukula N; Saha S; Jana SS; Ta M
    Cytotherapy; 2014 May; 16(5):640-52. PubMed ID: 24210786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive selection of Wharton's jelly-derived CD105(+) cells by MACS technique and their subsequent cultivation under suspension culture condition: A simple, versatile culturing method to enhance the multipotentiality of mesenchymal stem cells.
    Amiri F; Halabian R; Dehgan Harati M; Bahadori M; Mehdipour A; Mohammadi Roushandeh A; Habibi Roudkenar M
    Hematology; 2015 May; 20(4):208-16. PubMed ID: 25116042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and characterization of Wharton's jelly-derived multipotent mesenchymal stromal cells obtained from bovine umbilical cord and maintained in a defined serum-free three-dimensional system.
    Cardoso TC; Ferrari HF; Garcia AF; Novais JB; Silva-Frade C; Ferrarezi MC; Andrade AL; Gameiro R
    BMC Biotechnol; 2012 May; 12():18. PubMed ID: 22559872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.